Axsome Therapeutics, Inc. (AXSM) by event type
AXSM moves most on analyst upgrades — a median of +0.24% at 30 minutes across 18 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the AXSM overview →
How AXSM reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 715 of 2,717 | 18 | +0.24% | 56% | +0.97% |
| Coverage initiations 1,571 of 2,283 | 42 | -0.14% | 38% | +0.41% |
| Rating reiterations 1,845 of 3,522 | 222 | -0.00% | 49% | -0.12% |
| Price-target raises 1,507 of 1,790 | 41 | -0.17% | 37% | +0.14% |
| Price-target cuts 437 of 1,527 | 13 | +0.09% | 54% | -0.19% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how AXSM usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · AXSM overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Rubius Therapeutics, Inc. (RUBY) | 392 | -0.32% | 45% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 391 | +0.13% | 52% |
| RA PHARMACEUTICALS (RARX) | 391 | -0.04% | 45% |
| Checkpoint Therapeutics, Inc. (CKPT) | 389 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.